NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-5

  1. 351 Posts.
    lightbulb Created with Sketch. 123
    https://hotcopper.com.au/data/attachments/4672/4672175-7c8f1ebc571d3910e77e7c84f54acee1.jpg
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.